Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Neoplasms 12 Brain Neoplasms 6 Prostatic Neoplasms 5 Neoplasm Metastasis 4 Lung Neoplasms 4 Sarcoma 3 Multiple Myeloma 3 Melanoma 3 Glioblastoma 3 Gastrointestinal Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Thymus Neoplasms 2 Stomach Neoplasms 2 Sarcoma, Synovial 2 Rectal Neoplasms 2 Pain 2 Ovarian Neoplasms 2 Oligodendroglioma 2 Neuroendocrine Tumors 2 Nasopharyngeal Carcinoma 2 Mesothelioma 2 Liposarcoma 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Glioma 2 Fatigue 2 Colorectal Neoplasms 2

Interventions

Magnetic Resonance Spectroscopy 16 Hydroxyurea 7 Everolimus 7 Bevacizumab 7 lutetium Lu 177 dotatate 6 gallium Ga 68 dotatate 6 Radiosurgery 6 Proton Therapy 6 Specimen Handling 5 pembrolizumab 4 Surveys and Questionnaires 4 Surgical Procedures, Operative 4 Radiotherapy 4 Imatinib Mesylate 4 Cyclophosphamide 4 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 4 aldesleukin 3 abemaciclib 3 Tranexamic Acid 3 Temozolomide 3 Sunitinib 3 Sodium Chloride 3 Radiotherapy, Intensity-Modulated 3 Observation 3 Nivolumab 3 Ga(III)-DOTATOC 3 90Y-octreotide, DOTA-Tyr(3)- 3 vistusertib 2 trametinib 2 ribociclib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Meningioma × Quality of Life × Clear all

NCT07044076 2025-06-29

MenQOL

Centre Hospitalier St Anne

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡